20-5607803-A-G
Variant names:
Variant summary
Our verdict is Benign. The variant received -12 ACMG points: 0P and 12B. BP4_StrongBA1
The NM_019593.5(GPCPD1):c.-29+3039T>C variant causes a intron change involving the alteration of a non-conserved nucleotide. The variant allele was found at a frequency of 0.696 in 148,322 control chromosomes in the GnomAD database, including 37,019 homozygotes. In-silico tool predicts a benign outcome for this variant. No clinical diagnostic laboratories have submitted clinical-significance assessments for this variant to ClinVar.
Frequency
Genomes: 𝑓 0.70 ( 37019 hom., cov: 23)
Consequence
GPCPD1
NM_019593.5 intron
NM_019593.5 intron
Scores
2
Clinical Significance
Not reported in ClinVar
Conservation
PhyloP100: -1.20
Publications
14 publications found
Genes affected
GPCPD1 (HGNC:26957): (glycerophosphocholine phosphodiesterase 1) Predicted to enable glycerophosphocholine phosphodiesterase activity. Predicted to be involved in glycerophospholipid catabolic process. Predicted to act upstream of or within skeletal muscle tissue development. Predicted to be located in cytosol. [provided by Alliance of Genome Resources, Apr 2022]
Genome browser will be placed here
ACMG classification
Classification was made for transcript
Our verdict: Benign. The variant received -12 ACMG points.
BP4
Computational evidence support a benign effect (BayesDel_noAF=-0.98).
BA1
GnomAd4 highest subpopulation (AFR) allele frequency at 95% confidence interval = 0.864 is higher than 0.05.
Transcripts
RefSeq
Ensembl
| Gene | Transcript | HGVSc | HGVSp | Effect | Exon rank | TSL | MANE | Protein | Appris | UniProt |
|---|---|---|---|---|---|---|---|---|---|---|
| GPCPD1 | ENST00000379019.7 | c.-29+3039T>C | intron_variant | Intron 1 of 19 | 1 | NM_019593.5 | ENSP00000368305.4 | |||
| GPCPD1 | ENST00000718343.1 | c.-29+3039T>C | intron_variant | Intron 1 of 19 | ENSP00000520780.1 | |||||
| GPCPD1 | ENST00000481690.2 | n.-29+3039T>C | intron_variant | Intron 1 of 7 | 3 | ENSP00000488635.1 |
Frequencies
GnomAD3 genomes AF: 0.695 AC: 103074AN: 148220Hom.: 36976 Cov.: 23 show subpopulations
GnomAD3 genomes
AF:
AC:
103074
AN:
148220
Hom.:
Cov.:
23
Gnomad AFR
AF:
Gnomad AMI
AF:
Gnomad AMR
AF:
Gnomad ASJ
AF:
Gnomad EAS
AF:
Gnomad SAS
AF:
Gnomad FIN
AF:
Gnomad MID
AF:
Gnomad NFE
AF:
Gnomad OTH
AF:
We have no GnomAD4 exomes data on this position. Probably position not covered by the project.
GnomAD4 genome AF: 0.696 AC: 103163AN: 148322Hom.: 37019 Cov.: 23 AF XY: 0.689 AC XY: 49719AN XY: 72176 show subpopulations
GnomAD4 genome
AF:
AC:
103163
AN:
148322
Hom.:
Cov.:
23
AF XY:
AC XY:
49719
AN XY:
72176
show subpopulations
African (AFR)
AF:
AC:
34833
AN:
39944
American (AMR)
AF:
AC:
9038
AN:
14888
Ashkenazi Jewish (ASJ)
AF:
AC:
2280
AN:
3454
East Asian (EAS)
AF:
AC:
3629
AN:
5002
South Asian (SAS)
AF:
AC:
2975
AN:
4698
European-Finnish (FIN)
AF:
AC:
5074
AN:
9900
Middle Eastern (MID)
AF:
AC:
201
AN:
286
European-Non Finnish (NFE)
AF:
AC:
43140
AN:
67202
Other (OTH)
AF:
AC:
1411
AN:
2060
Allele Balance Distribution
Red line indicates average allele balance
Average allele balance: 0.497
Heterozygous variant carriers
0
1380
2760
4140
5520
6900
0.00
0.20
0.40
0.60
0.80
0.95
Allele balance
Age Distribution
Genome Het
Genome Hom
Variant carriers
0
790
1580
2370
3160
3950
<30
30-35
35-40
40-45
45-50
50-55
55-60
60-65
65-70
70-75
75-80
>80
Age
Alfa
AF:
Hom.:
Bravo
AF:
Asia WGS
AF:
AC:
2327
AN:
3476
ClinVar
Not reported inComputational scores
Source:
Name
Calibrated prediction
Score
Prediction
BayesDel_noAF
Benign
DANN
Benign
PhyloP100
Splicing
Name
Calibrated prediction
Score
Prediction
SpliceAI score (max)
Details are displayed if max score is > 0.2
Find out detailed SpliceAI scores and Pangolin per-transcript scores at
Publications
You must be logged in to view publications. This limit was set because tens of millions (!) of queries from AI bots are generated daily.